Definition of a molecular pathway mediating α-synuclein neurotoxicity - Test2 - elhamkhani - TriplyDB

Definition of a molecular pathway mediating α-synuclein neurotoxicity

Definition of a molecular pathway mediating α-synuclein neurotoxicity

http://www.wikidata.org/entity/Q26269832

about

Dynamic structural flexibility of α-synuclein Neuroinflammation in Multiple System Atrophy: Response to and Cause of α-Synuclein Aggregation The associations between Parkinson's disease and cancer: the plot thickens Αlpha-Synuclein as a Mediator in the Interplay between Aging and Parkinson's Disease The Synaptic Function of α-Synuclein Alpha-Synuclein in Parkinson's Disease: From Pathogenetic Dysfunction to Potential Clinical Application Cuminaldehyde as the Major Component of Cuminum cyminum, a Natural Aldehyde with Inhibitory Effect on Alpha-Synuclein Fibrillation and Cytotoxicity Characterization of α-Synuclein Multimer Stoichiometry in Complex Biological Samples by Electrophoresis Seeding and transgenic overexpression of alpha-synuclein triggers dendritic spine pathology in the neocortex Effects of impaired membrane interactions on α-synuclein aggregation and neurotoxicity KTKEGV repeat motifs are key mediators of normal α-synuclein tetramerization: Their mutation causes excess monomers and neurotoxicity.shRNA-Based Screen Identifies Endocytic Recycling Pathway Components That Act as Genetic Modifiers of Alpha-Synuclein Aggregation, Secretion and Toxicity.Mannose 6-Phosphate Receptor Is Reduced in -Synuclein Overexpressing Models of Parkinsons Disease.Altered machinery of protein synthesis is region- and stage-dependent and is associated with α-synuclein oligomers in Parkinson's disease.Elucidating the Aβ42 Anti-Aggregation Mechanism of Action of Tramiprosate in Alzheimer's Disease: Integrating Molecular Analytical Methods, Pharmacokinetic and Clinical Data Bent out of shape: α-Synuclein misfolding and the convergence of pathogenic pathways in Parkinson's disease.Atomic-level description of protein-lipid interactions using an accelerated membrane model.G2019S-LRRK2 Expression Augments α-Synuclein Sequestration into Inclusions in Neurons.Nuclear Magnetic Resonance Observation of α-Synuclein Membrane Interaction by Monitoring the Acetylation Reactivity of Its Lysine Side Chains.Beyond the SNARE: Munc18-1 chaperones α-synuclein.The Synucleinopathies: Twenty Years On.Structure, function and toxicity of alpha-synuclein: the Bermuda triangle in synucleinopathies.Neuropathology of α-synuclein propagation and braak hypothesis.Targeting the Autophagy/Lysosomal Degradation Pathway in Parkinson's Disease.Protein Partners of α-Synuclein in Health and Disease.Alpha-synuclein modulates retinal iron homeostasis by facilitating the uptake of transferrin-bound iron: Implications for visual manifestations of Parkinson's disease.Cell Biology and Pathophysiology of α-Synuclein.The Contribution of α-Synuclein Spreading to Parkinson's Disease Synaptopathy.The Role of Lipids Interacting with α-Synuclein in the Pathogenesis of Parkinson's Disease.Modulating membrane binding of α-synuclein as a therapeutic strategy.Selective lowering of synapsins induced by oligomeric α-synuclein exacerbates memory deficits.Loss of native α-synuclein multimerization by strategically mutating its amphipathic helix causes abnormal vesicle interactions in neuronal cells.Nortriptyline inhibits aggregation and neurotoxicity of alpha-synuclein by enhancing reconfiguration of the monomeric form.Levator ani muscle innervation: Anatomical study in human fetus.Stimulation of synaptoneurosome glutamate release by monomeric and fibrillated α-synuclein.A de novo compound targeting α-synuclein improves deficits in models of Parkinson's disease.α-Synuclein Dimers Impair Vesicle Fission during Clathrin-Mediated Synaptic Vesicle Recycling.Neurodegeneration and the ordered assembly of α-synuclein.Clearing Extracellular Alpha-Synuclein from Cerebrospinal Fluid: A New Therapeutic Strategy in Parkinson's Disease.Rab GTPases and Membrane Trafficking in Neurodegeneration.

P2860

Q26770060-AE0B0077-7BB2-47F4-806E-0BFF8AEA3214 Q26771536-326F44D5-4875-4486-94D2-C8BA15C1A0C1 Q26778641-E6FF54FF-D2EE-4FC9-8928-4E29362D77FA Q26778937-84BE644D-31FB-443D-9FF2-C096547E9678 Q27694711-13E0E14A-418E-4437-99C6-B00CCC05A9EC Q28079911-C857D180-C4B1-4E23-AC43-E69053478A00 Q28267154-89C19778-3F86-4FE9-9FD5-2BAA839187D3 Q28828388-0C583F39-5CC9-477C-9548-62467F0E4AAF Q33625757-EA137AB8-A69A-4FFF-9C70-7CE36B593509 Q35691076-54276C59-9594-4339-BC64-8DCCB8C48A59 Q35946269-B9CAB643-A75B-47DD-88DB-4863A4ED264D Q36001639-77E982A8-DA53-4B3C-BBEB-F66C66A8A110 Q36100354-16FB44F4-1A3B-4D8F-B89B-5468C0C098E1 Q36336723-96C0CC0B-7757-470F-AEAF-6B2684F5BF83 Q36354749-34E92A43-8781-449D-BAE0-F2BDA1355076 Q36373170-AAAF9B02-53FC-4FE9-9116-CFF20B818179 Q36927711-5E9D395D-D812-4C2A-99A8-B3D0905E2F23 Q37096048-46A18E2B-6032-4418-9505-FD4E9AABD8A1 Q37241387-6E2F1D89-46FA-4A87-89EB-30C253B4356D Q37252444-2FFA6FE8-827C-4C4F-B129-ACBEF6EEC325 Q37693375-9F088377-61D5-438A-8748-6A278ECD2330 Q38550428-E3B5DBEA-0746-4EEB-84EE-75FBEB47714C Q38580816-A7F91C9D-0878-440E-B88A-BF5B919AA95F Q38620227-01D59B14-039E-4D09-98F9-58C4F64F72D0 Q38759798-56DE0354-A897-44B1-9D84-BAE4E4853488 Q38762283-0CBDE5D9-4E85-4F16-B8CC-377D9DC95E21 Q39097048-B03DCE25-A702-4BC7-97EA-508B69AB5B6A Q39108546-A81FE22C-F21F-43AE-A863-6E2A2894BE1B Q39410832-2CC31F22-0249-47D1-A5A6-702B187B232F Q42321742-E4A337F4-E286-4AE9-AC2D-C271B9459CFA Q46362244-1176B60C-0EF2-4C5C-BAB8-0F33DDA9DC25 Q47801119-1B47833E-C0D7-4E20-A3A5-6AD3965AFDBB Q47826150-B90801B1-94C4-4FA6-B3ED-B1F9A5B1AE3B Q47955037-8B1C2186-5492-41C0-AD1C-85E43E2C011C Q48342632-98B36F70-14EE-4888-8FC5-6DDD90E8843C Q48493933-0FD7C405-5626-40D1-8433-F0B5AFF9B2B4 Q49330024-95B70FC0-95BA-4E01-9443-67856B0A77A6 Q50101026-AF8CE0F1-BF21-41EF-90EE-2EF0A9744760 Q51732038-FDB86873-4DEE-4004-9FDD-2177D78B2AE3 Q52804356-6935C2A3-F722-4315-917E-B53A77660368

P2860

Definition of a molecular pathway mediating α-synuclein neurotoxicity

http://www.wikidata.org/entity/Q26269832

description

2015 nî lūn-bûn

@nan

2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Definition of a molecular pathway mediating α-synuclein neurotoxicity

@ast

Definition of a molecular pathway mediating α-synuclein neurotoxicity

@en

Definition of a molecular pathway mediating α-synuclein neurotoxicity

@nl

type

label

Definition of a molecular pathway mediating α-synuclein neurotoxicity

@ast

Definition of a molecular pathway mediating α-synuclein neurotoxicity

@en

Definition of a molecular pathway mediating α-synuclein neurotoxicity

@nl

prefLabel

Definition of a molecular pathway mediating α-synuclein neurotoxicity

@ast

Definition of a molecular pathway mediating α-synuclein neurotoxicity

@en

Definition of a molecular pathway mediating α-synuclein neurotoxicity

@nl

P1433

Q26269832-C9A58427-EC82-424E-9122-B2C6F90F395A

P1476

Q26269832-B3C65562-8425-4CD1-B33F-A2E9A7D9B7FB

P2093

Q26269832-C12DB290-D52E-4A92-9DA3-AE195597B9BC

P2860

Q26269832-007DC501-057F-4A31-9FE4-61A82BE138DE

Q26269832-04BB1F4D-1F83-4F76-B6BD-C804D3341FA5

Q26269832-10D5565C-3EC8-4A54-9998-31BF35E0E3DE

Q26269832-11D27BE5-02C0-471F-81E7-E84E16C0AAD7

Q26269832-13533EDF-49C9-4070-82EB-47928E810E80

Q26269832-193C9DAD-FD3A-4E8F-B895-B5AEA471FA13

Q26269832-1A6B611D-05B9-4C14-A040-39C8EDDD65B7

Q26269832-1A9459A6-F4E5-47BD-A16C-A36240333D92

Q26269832-1E4401A5-8AD9-47D5-9B84-7A8C3D90C35B

Q26269832-2EDA7AE4-467B-47E5-8933-5BDCF097B90B

P304

Q26269832-81CF4FD8-5C79-4297-B4A7-B46B3447AE64

P31

Q26269832-F9353D3A-7111-4AB6-A76B-7E1AF4E29236

P3181

Q26269832-3C977E3F-123F-4C81-B758-749DCE2B0BD0

P356

Q26269832-DF33E249-1F09-4649-8D03-DA3CE4D2E9ED

P407

Q26269832-0FA68A6D-393B-4D1E-9149-DB6150D68301

P433

Q26269832-A0389EDF-A6ED-458B-BA65-21FE20AC72EB

P478

Q26269832-982190F7-44EB-468A-B977-C8D1BDB61E71

P50

Q26269832-2B497393-6369-47CD-B49A-8B619CB8D6E1

Q26269832-6DDBB66B-AE2A-420E-966B-40B16842EC48

P577

Q26269832-1D1532CF-3786-4665-85E4-9F71A16B98BB

P698

Q26269832-C4C485F4-CCA0-4A59-A321-F293416BA670

P921

Q26269832-7AC98549-E979-4182-8406-F076E402DF35

Q26269832-FFAB0A57-65B7-4EEC-9C79-8B0E99C38FE7

P932

Q26269832-2D8C6A74-A4B4-4D98-8FA5-6199256B2CF3

P3181

P356

JNEUROSCI.4650-14.2015

P1433

Journal of Neuroscience

P1476

Definition of a molecular pathway mediating α-synuclein neurotoxicity

@en

P2093

Manu Sharma

http://www.w3.org/2001/XMLSchema#string

P2860

Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro

alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies

Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

α-Synuclein assembles into higher-order multimers upon membrane binding to promote SNARE complex formation

Properties of native brain α-synuclein

Systematic mutagenesis of α-synuclein reveals distinct sequence requirements for physiological and pathological activities

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

alpha-Synuclein locus triplication causes Parkinson's disease

Alpha-synuclein in Lewy bodies

P304

5221-32

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2024295

http://www.w3.org/2001/XMLSchema#string

P356

10.1523/JNEUROSCI.4650-14.2015

http://www.w3.org/2001/XMLSchema#string

P407

P433

13

http://www.w3.org/2001/XMLSchema#string

P478

35

http://www.w3.org/2001/XMLSchema#string

P50

Jacqueline Burré

Thomas C. Südhof

P577

2015-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25834048

http://www.w3.org/2001/XMLSchema#string

P921

P932

4380997

http://www.w3.org/2001/XMLSchema#string